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Abstract: Subependymomas are a rare subtype of ependymomas, slow growing WHO 
grade I tumors that develop either intracranial from the subependymal glial precursor 
cells layer of the ventricles or intramedullary. These tumors originate in the 
undifferentiated Subependymal layer of cells that can become either ependymocytes or 
astrocytes. Most of the subependymomas are located inside the fourth ventricle (50-
60%). We reviewed the case of a 40 years old woman with a giant solid cystic fourth 
ventricle ependymoma. The patient underwent total resection of the tumor through a 
subociipital transvermian approach. We discussed the characteristics of these benign 
tumors and reviewed the literature on this subject and concluded that total resection is 
the treatment of choice for symptomatic Subependymomas localized in posterior fossa. 
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Introduction 
Subependymomas are a rare subtype of 
ependymomas, slow growing WHO grade I 
tumors that develop either intracranial from 
the subependymal glial precursor cells layer of 
the ventricles or intramedullary.[7,13] 
Ependymomas are more frequent in pediatric 
patients accounting for 6–12% of all 
intracranial tumours. The intramedullary 
location is the most frequent, these tumors 
accounting for 50-60% of all spinal cord 
lesions. The term of subependymomas was 
coined in 1945 and since than many authors 
published only case reports, reflecting the 
rarity of this tumor, with an incidence between 
0,2% and 0,7%. [8] Most of the 
subependymomas are located inside the fourth 
ventricle (50-60%) and become symptomatic 
when large enough to compress the 
cerebellum, the floor of the fourth ventricle or 
to obstruct the CSF flow with progressing 
secondary hydrocephalus [10].  These tumors 
originate in the undifferentiated 
Subependymal layer of cells that can become 
either ependymocytes or astrocytes [3]. A few 
reports documented the familial occurrence of 
subependymoma.  
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Case report  
A 40 years old woman presented with an 8 
months history of intense headache nausea 
and vomiting, signs of increased intracranial 
pressure, posture and gait ataxia, horizontal 
nystagmus walking fatigueability and 
paresthesia in both inferior limbs.  Her eye 
exam showed a mild bilateral papilledema.  
A brain MRI revealed a well-delimitated 
tumor occupying the caudal part of the fourth 
ventricle with an associated cyst on the 
superior aspect compressing the vermis and 
cerebellar hemispheres. The solid portion was 
inhomogeneous on T1 showing moderate and 
irregular enhancement, a hypointense core 
and periphery and a hyperintense ring, sign of 
intratumoral bleeding in between. (Figure 1). 
The tumor also showed microcalcifications 
around the hypodense core on CT scan.  
Surgery  
The patient was placed in prone position 
with the head slightly elevated and flexed for a 
better opening of the space between the 
occiput and C1.  Using a midline occiput C6 
incision, a bilateral suboccipital craniotomy 
was performed including the posterior C1 
arch.  Opening the arachnoid over the cisterna 
magna relieved CSF under pressure and 
relaxed the cerebellum. The inferior pole of the 
tumor became visible in the 
cerebellomedullary fissure as it enlarged the 
foramen Magendie and displaced the 
cerebellar hemispheres laterally and the 
vermis superiorly. 
 
 
 
Figure 1 - Frontal, axial and sagittal Preop MRI 
showing a giant IV ventricular lesion, with solid and 
cystic component presenting some core 
hipo/hyperintensities. The lesion compresses the 
brainstem and the cystic component displaces the 
vermis reaching the tentorium 
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Figure 2 - a) the suboccipital approach was 
performed, and the arachnoid opened showing 
centrally a large tumor that displaces the cerebellar 
hemispheres laterally invading most of the cysterna 
magna. b,c) the tumor is internally debulked until the 
cystic portion is reached and a dark yellow viscous 
fluid is aspirated. d) the tumor is circumferentially 
dissected from the parenchima without traction , and 
resected piecemeal. E) the floor of the IV ventricle is 
visible between some tumor portions attached to the 
inferior vellum. F) final aspect, after gross total 
resection was achieved with the white floor of the IVth 
ventricle visible between the tonsils 
 
 
Figure 3 - the 2nd day postoperative CT scan showng 
no tumor remnant 
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A big portion of the tumor was bulging into 
the cisterna magna and the first step in 
approaching it was internal debulking and 
aspiration of the dark yellow cyst fluid, 
Incision of the vermis revealed a firm 
lobulated tumor that entirely occupied the 
cavity of the fourth ventricle. Step by step, the 
tumor capsule was detached from the 
surrounding tissue, with fine movements 
avoiding traction on the walls of the IVth 
ventricle. Using cotton pledges in the plane 
between the tumor and parenchima eased the 
dissection. As the tumor was firm and not 
attached to the floor of the ventricle it could be 
removed piecemeal. Frozen-section 
examination of a tumor specimen revealed the 
typical histological picture of 
subependymoma. We did not encounter 
important bleeding from the tumor during 
resection.   
Immediately postoperative the ataxia, 
nistagmus and the signs of increased 
intracranial pressure disappeared but she 
presented mild transitory dysphagia. Her 
sensibility improved to normal at 2 months 
follow up.   The pathology result confirmed the 
diagnostic of subependimoma.  
Discussion 
These benign WHO Grade 1[15], soft 
tumors are asymptomatic until they reach an 
important size even when localized in IVth 
ventricle so many of them are autopsy reports, 
with an incidence of 0,4% [9] Scheithauer et 
al.[12] reported  21 cases of symptomatic  large 
Subependymomas,  8.3% of a large series of 
ependymomas,  11 of which were located in 
the fourth ventricle.  A 10 years span 
retrospective study on Subependymomas 
performed at Beijing Tiantan Hospital 
analyzed 43 patients (0.07% of 60000 surgical), 
7 of which were located in the fourth ventricle 
[2].  Most of the tumors in this study 90% were 
located in the ventricular system, and most of 
them presented a multicystic pattern on MRI.  
P. Clarenbach et al. reported 
subependymomas of the fourth ventricle in 
identical twins suggesting that that not only 
histology and topology but also growth 
dynamics were prenatally determined. [5]  
Both CT scan and MRI are useful in 
orienting the preoperative diagnosis towards 
subependymoma by comparison with 
medulloblastoma and low-grade astrocytoma, 
the other frequent fourth ventricle neoplasms, 
sometimes the resemblance of 
subependymomas with astrocytomas is so big 
in both T1 and T2 MRI sequences that only the 
presence of microcysts can make the 
difference.  The MRI characteristics of 
subependymomas are nonspecific, but MRI 
spectroscopy showing normal 
Choline/Creatinine peaks and decreased NAA 
peak can help in directing the diagnosis. [4, 6] 
Our patient had no cranial nerve deficits 
given by compression of forth ventricle floor 
because the tumor enlarged the foramen 
Magendie and was expressed in the cisterna 
magna displacing the vermis superiorly and 
the tonsils and cerebellar hemispheres 
laterally. The tumor was approached using a 
transvermian approach as we considered this 
better than telovelar approach, for large 
tumors that cross into the cisterna magna 
through the foramen of Magendie.   
There are reports of transitory akinetic 
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mutism associated with the transvermian 
approach, yet we didn’t encounter such cases 
in our experience [14]. We consider that in big 
tumors inside the IVth ventricle especially 
those attached to the roof, this approach is 
better than the telovelar approach. For most 
tumors involving the floor of the IVth ventricle 
we prefer the telovelar approach. Like most 
cases reviewed in literature, our case had a 
mixt cystic solid aspect that made the resection 
easier. Once the cyst was punctured, enough 
space was gained for the circumferential 
dissection of the tumor from the adiacent 
parenchima. The tumor did not infiltrate the 
floor of the fourth ventricle which explained 
the lack of cranial nerve deficits at 
presentation.  
Gross total resection is the main treatment, 
assuring a Long-term survival. A study from 
Barrow institute compared gross total 
resesction (GTR) with GTR followed by 
radiotherapy found a statistical superiority for 
the latter in terms of improving the long term 
local control [11]. Our treatment protocol for 
posterior fossa ependymomas also includes 
postoperative radiotherapy that is efficient in 
recurrences control and well tolerated by the 
patients, but we don’t recommend it for 
subependymomas. 
There were previous reports of using 5 
ALA for a better identification of the tumor 
margins [1]. This technique was not available 
in our case but the tumor was well 
encapsulated and the gross total resection 
could be documented by simple inspection.  
 
 
Conclusions 
Total resection is the treatment of choice 
for symptomatic Subependymomas localized 
in posterior fossa. A meticulous surgical 
technique is the mainstay of a favorable 
outcome for the tumors located in the fourth 
ventricle. The choice of the approach should 
balance the extent of access to the tumor with 
the risk of damaging surrounding eloquent 
structures. 
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